Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Martin Roper, CEO and Director of Vita Coco Company, Inc. (COCO), reported open-market sales of common stock executed under a Rule 10b5-1 trading plan on September 22 and 23, 2025. The filing shows two sales by the reporting person of 5,000 shares on 09/22/2025 and 5,000 shares on 09/23/2025 at weighted-average prices in the ~$40.14–$40.52 range, leaving 324,297 shares held directly after the 09/23 sale. The form also discloses multiple indirect holdings through family trusts and a spouse, and a total of 1,099,460 outstanding stock options across several grant dates and exercise prices, including fully vested options exercisable now.
Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported transactions on 09/22/2025. He sold 20,000 shares of common stock pursuant to a Rule 10b5-1 trading plan at a weighted average price of $41.535 per share. The Form 4 shows he beneficially owns 1,529,049 shares indirectly through the Michael Kirban 2010 Trust and additional holdings reflected as direct and indirect positions. The filing also lists multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and varying vesting or exercisability dates.
Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported transactions on 09/22/2025. He sold 20,000 shares of common stock pursuant to a Rule 10b5-1 trading plan at a weighted average price of $41.535 per share. The Form 4 shows he beneficially owns 1,529,049 shares indirectly through the Michael Kirban 2010 Trust and additional holdings reflected as direct and indirect positions. The filing also lists multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and varying vesting or exercisability dates.
Martin Roper, a director and CEO of Vita Coco Company, Inc. (COCO), amended a Form 4 to report multiple sales of common stock executed pursuant to a Rule 10b5-1 trading plan on September 15–17, 2025. The Form 4/A shows a series of disposals reported as sales (code S) that reduced both direct and indirect beneficial holdings and reports weighted-average prices for the transactions in ranges approximately between $40.00 and $40.54 per share. The filing also discloses several fully vested and unvested non‑qualified stock options exercisable for large blocks of common stock, with exercise prices from $10.178 to $32.78 and various vesting schedules and expiration dates through 2035. The amendment restates the original Form 4 filed September 18, 2025.
Martin Roper, a director and CEO of Vita Coco Company, Inc. (COCO), amended a Form 4 to report multiple sales of common stock executed pursuant to a Rule 10b5-1 trading plan on September 15–17, 2025. The Form 4/A shows a series of disposals reported as sales (code S) that reduced both direct and indirect beneficial holdings and reports weighted-average prices for the transactions in ranges approximately between $40.00 and $40.54 per share. The filing also discloses several fully vested and unvested non‑qualified stock options exercisable for large blocks of common stock, with exercise prices from $10.178 to $32.78 and various vesting schedules and expiration dates through 2035. The amendment restates the original Form 4 filed September 18, 2025.
Martin Roper, a director and CEO of Vita Coco Company, Inc. (COCO), amended a Form 4 to report multiple sales of common stock executed pursuant to a Rule 10b5-1 trading plan on September 15–17, 2025. The Form 4/A shows a series of disposals reported as sales (code S) that reduced both direct and indirect beneficial holdings and reports weighted-average prices for the transactions in ranges approximately between $40.00 and $40.54 per share. The filing also discloses several fully vested and unvested non‑qualified stock options exercisable for large blocks of common stock, with exercise prices from $10.178 to $32.78 and various vesting schedules and expiration dates through 2035. The amendment restates the original Form 4 filed September 18, 2025.
Vita Coco insider Form 4: Martin Roper stock sales and option holdings. The filing reports that Martin Roper, CEO and director, sold four blocks of common stock on 09/18/2025 pursuant to a Rule 10b5-1 trading plan, disposing of 5,000 shares in his name and 5,000 shares each tied to three family trusts for a total reported disposals of 20,000 shares at weighted average prices around $40.00–$40.11 per share. The filing also discloses substantial currently exercisable and non-exercisable non-qualified stock options totaling 1,098,460 underlying shares across multiple grants with exercise prices ranging from $10.178 to $32.78.
Vita Coco insider Form 4: Martin Roper stock sales and option holdings. The filing reports that Martin Roper, CEO and director, sold four blocks of common stock on 09/18/2025 pursuant to a Rule 10b5-1 trading plan, disposing of 5,000 shares in his name and 5,000 shares each tied to three family trusts for a total reported disposals of 20,000 shares at weighted average prices around $40.00–$40.11 per share. The filing also discloses substantial currently exercisable and non-exercisable non-qualified stock options totaling 1,098,460 underlying shares across multiple grants with exercise prices ranging from $10.178 to $32.78.
Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported multiple transactions on 09/17/2025 under a Rule 10b5-1 plan. He purchased 20,000 shares via option exercises at a stated exercise price of $10.178 per share (reported as two non-qualified option exercises of 10,000 shares each) and sold 20,000 shares in Rule 10b5-1 plan transactions at a weighted average price of $42.04 per share (sales occurred across prices ranging from $42.00 to $42.19 and $42.00 to $42.18 as disclosed). Following the reported non-derivative transactions, his direct beneficial ownership figures listed are 94,328 shares and 84,328 shares on the lines reported.
Table II shows multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including currently exercisable options and several tranches that vest over future years, totaling significant option-based potential ownership.
Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported multiple transactions on 09/17/2025 under a Rule 10b5-1 plan. He purchased 20,000 shares via option exercises at a stated exercise price of $10.178 per share (reported as two non-qualified option exercises of 10,000 shares each) and sold 20,000 shares in Rule 10b5-1 plan transactions at a weighted average price of $42.04 per share (sales occurred across prices ranging from $42.00 to $42.19 and $42.00 to $42.18 as disclosed). Following the reported non-derivative transactions, his direct beneficial ownership figures listed are 94,328 shares and 84,328 shares on the lines reported.
Table II shows multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including currently exercisable options and several tranches that vest over future years, totaling significant option-based potential ownership.
Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of common stock on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $40.034 (individual trade prices ranged from $39.65 to $40.22). After the sale he beneficially owned 623,866 shares. The filing also discloses a fully vested, currently exercisable non-qualified stock option covering 27,300 underlying shares with a $10.178 exercise price. The Form 4 was filed by an attorney-in-fact on behalf of the reporting person and identifies the sale as pre-arranged under Rule 10b5-1.
Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of common stock on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $40.034 (individual trade prices ranged from $39.65 to $40.22). After the sale he beneficially owned 623,866 shares. The filing also discloses a fully vested, currently exercisable non-qualified stock option covering 27,300 underlying shares with a $10.178 exercise price. The Form 4 was filed by an attorney-in-fact on behalf of the reporting person and identifies the sale as pre-arranged under Rule 10b5-1.
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.
Insider sale under a Rule 10b5-1 plan: Liran Ira, a director of Vita Coco Company, Inc. (COCO), reported selling 50,000 shares of the issuer's common stock on 09/17/2025 at a weighted average price of $42.003 per share. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. After the reported transactions, the form discloses 598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Insider sale under a Rule 10b5-1 plan: Liran Ira, a director of Vita Coco Company, Inc. (COCO), reported selling 50,000 shares of the issuer's common stock on 09/17/2025 at a weighted average price of $42.003 per share. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. After the reported transactions, the form discloses 598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.
Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.
Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc. (COCO), reported related transactions on 09/17/2025. He acquired 16,827 shares by exercising non-qualified stock options at an exercise price of $10.178 per share and sold 16,827 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.546 per share (sales ranged from $42.50 to $42.73). Following these transactions his beneficial ownership of common stock decreased from 92,954 shares to 76,127 shares. The filing also lists multiple outstanding non-qualified stock options exercisable and unexercisable, with strike prices ranging from $10.178 to $33.36 and various vesting schedules.
Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc. (COCO), reported related transactions on 09/17/2025. He acquired 16,827 shares by exercising non-qualified stock options at an exercise price of $10.178 per share and sold 16,827 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.546 per share (sales ranged from $42.50 to $42.73). Following these transactions his beneficial ownership of common stock decreased from 92,954 shares to 76,127 shares. The filing also lists multiple outstanding non-qualified stock options exercisable and unexercisable, with strike prices ranging from $10.178 to $33.36 and various vesting schedules.